uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Amyloidogenic potential of foie gras
Show others and affiliations
2007 (English)In: Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, E-ISSN 1091-6490, Vol. 104, no 26, 10998-11001 p.Article in journal (Refereed) Published
Abstract [en]

The human cerebral and systemic amyloidoses and prion-associated spongiform encephalopathies are acquired or inherited protein folding disorders in which normally soluble proteins or peptides are converted into fibrillar aggregates. This is a nucleation-dependent process that can be initiated or accelerated by fibril seeds formed from homologous or heterologous amyloidogenic precursors that serve as an amyloid enhancing factor (AEF) and has pathogenic significance in that disease may be transmitted by oral ingestion or parenteral administration of these conformationally altered components. Except for infected brain tissue, specific dietary sources of AEF have not been identified. Here we report that commercially available duck- or goose-derived foie gras contains birefringent congophilic fibrillar material composed of serum amyloid A-related protein that acted as a potent AEF in a transgenic murine model of secondary (amyloid A protein) amyloidosis. When such mice were injected with or fed amyloid extracted from foie gras, the animals developed extensive systemic pathological deposits. These experimental data provide evidence that an amyloid-containing food product hastened the development of amyloid protein A amyloidosis in a susceptible population. On this basis, we posit that this and perhaps other forms of amyloidosis may be transmissible, akin to the infectious nature of prion-related illnesses.

Place, publisher, year, edition, pages
2007. Vol. 104, no 26, 10998-11001 p.
Keyword [en]
Amyloidosis/chemically induced/*etiology, Animals, Disease Models, Animal, Ducks, Geese, Glycoproteins/administration & dosage/pharmacology, Meat Products/*adverse effects, Mice, Transgenic, Serum Amyloid A Protein/*administration & dosage/pharmacology
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-16698DOI: 10.1073/pnas.0700848104ISI: 000247641900046PubMedID: 17578924OAI: oai:DiVA.org:uu-16698DiVA: diva2:44469
Available from: 2008-06-03 Created: 2008-06-03 Last updated: 2011-01-29Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=17578924&dopt=Citation

Search in DiVA

By author/editor
Westermark, Per
By organisation
Department of Genetics and Pathology
In the same journal
Proceedings of the National Academy of Sciences of the United States of America
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 318 hits
ReferencesLink to record
Permanent link

Direct link